
There are currently two specifications of Lorlatinib produced by Lucius, namely 25mg30 tablets and 100mg30 tablets.
If you wish to purchase Lorlatinib, you can contact us via the homepage.
The price of lorlatinib varies significantly, mainly depending on the drug source (innovator or gene···【more】
Recommended:112026-23-01
This drug is a prescription medicine. Its use must strictly follow the doctor’s instructions, and it···【more】
Recommended:112026-23-01
The price of Lorlatinib is subject to significant fluctuations due to the impacts of regions, purcha···【more】
Recommended:112026-23-01
The monthly treatment cost of lorlatinib currently available in China fluctuates according to specif···【more】
Recommended:132026-23-01
The price of lorlatinib varies significantly, mainly depending on the drug source (innovator or generic), availability of medical insurance reimbursement, and purchase channel.Late···【more】
Article source:Lucius LaosRelease date:2026-01-23Recommended:11
This drug is a prescription medicine. Its use must strictly follow the doctor’s instructions, and it shall not be purchased or dosed without authorization.What is the price of one ···【more】
Article source:Lucius LaosRelease date:2026-01-23Recommended:11
The price of Lorlatinib is subject to significant fluctuations due to the impacts of regions, purchase channels, dosage specifications, and medical insurance policies.What is the P···【more】
Article source:Lucius LaosRelease date:2026-01-23Recommended:11
The monthly treatment cost of lorlatinib currently available in China fluctuates according to specifications and regional differences, and may change in the future with the adjustm···【more】
Article source:Lucius LaosRelease date:2026-01-23Recommended:13
Patients with non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) rearrangement or ROS proto-oncogene 1 (ROS1) rearrangement are generally sensitive to tyrosin···【more】
Article source:Lucius LaosRelease date:2024-11-20Recommended:250
Lorlatinib is a highly potent third-generation ALK and ROS1 tyrosine kinase inhibitor with good brain penetration and broad coverage of ALK mutations. In a phase 1 study, it showed···【more】
Article source:Lucius LaosRelease date:2024-11-20Recommended:276

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: